TRUST vs BR.21: an indirect comparison
{"Image DocumentName": "TRUST vs BR.21: an indirect comparison", "Image ImageDescription": "Overall Survival in UE Subpopulation BR.211. Median OS: erlotinib 6.7 mo vs placebo 4.7 mo (p<0.001) TRUST 2. Median OS: 7.9 months (28% censored) Survival distribution function. Erlotinib (TRUST), n=6,580. Erlotinib (BR.21), n=488. Placebo (BR.21), n= Survival time (months) 1Shepherd FA, et al. N Engl J Med M Reck et al, ESMO 2008.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}